£97.00

CRC Press Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)

Price data last checked 48 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 43 days • 43 data points (No recent data available)

Historical
Generating forecast...
£99.95 £96.57 £97.31 £98.05 £98.78 £99.52 £100.26 25 January 2026 04 February 2026 15 February 2026 25 February 2026 08 March 2026

Price Distribution

Price distribution over 43 days • 3 price levels

Days at Price
Current Price
20 days · current 9 days 14 days 0 5 10 15 20 £97 £99 £100 Days at Price

Price Analysis

Most common price: £97 (20 days, 46.5%)

Price range: £97 - £100

Price levels: 3 different prices over 43 days

Description

Product Description Nervous system diseases represent a major health concern worldwide. Although important financial and professional investment, their etiology and pathophysiology still remain mostly elusive. Moreover, the clinical need of disease-modifying therapies is still unmet. In the last decades, traditional R&D has failed in identifying new effective therapies in many medical areas and drug repositioning has recently emerged as a promising alternative strategy to de novo drug discovery to improve and accelerate therapeutic development. For the first time, Drug Repositioning: Approaches and Applications for Neurotherapeutics reviews history and advances in drug repositioning, with a special focus on therapeutics for nervous system diseases. International experts from Academia, Industry and Non-profit organisations will provide different views on drug repositioning advantages, challenges and specific applications, which will be covered for nervous system diseases including Alzheimer's, Parkinson's, Huntington's diseases, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, ischemic stroke, and psychiatric disorders. This book provides a balanced overview and synthesis of drug repositioning concept, methods and applications for neurotherapeutics. It represents a valuable resource for students, scientists and clinicians working in academic settings, industry and government agencies within the fields of neuroscience, pharmacology, neurology, pharmaceutical sciences, drug discovery and development. Review This excellent book is a must read for those interested in drug-repositioning and those involved in the hunt for new effective neurotherapeutics. The introductory sections of the book provide not only a clear explanation of the merits of repositioning but also an honest consideration of the difficulties of the approach. This is well illustrated by examples from the fields of Alzheimer’s and Parkinson’s describing successes and failures.  Also introduced is the value of drug-repositioning to not-for profit organisations. Which adds to those who are involved in medical charity research to list of those who should read this publication. For the reader whose interest is piqued by the possibilities of drug repositioning and want to know more of the mechanics following chapters explore a variety of techniques that can be adopted for the identification of candidate repositioned therapies.  Again, these an honest consideration with both pro and cons described.   This makes the publication useful reading for any interested in repositioning irrespective of their field of interest. The latter sections focus on repositioning for a very diverse range of CNS conditions. These include Parkinson’s, Alzheimer’s, Huntingdon’s, ALS, Spinal muscular atrophy and Ischaemic injury.  For those with specific interests in any of the above this is a useful work.  But in addition, I would recommend to those with a specific CNS disease interest reading the other chapters as they provide a potentially useful insight into methods and approaches than could be adopted within a specific interest.Taken together this is valuable read and reference work for a diverse readership. - Dr Alan Rothaul, Re-Pharm Drug repositioning, also known as repurposing, seems an easy and straight forward route for the successful development of drugs. However, aspects of value creation and sound business cases are still essential, even if a drug has been fully or partly developed before. Complexity is added to this situation by applying repurposing to the area of neurodegenerative diseases: pathogenesis of Parkinson’s, Alzheimer’s and other neurologic diseases of the higher ages are still poorly understood. Nevertheless, there is hope in repurposing even for this very difficult indication area, increasingly neglected by pharma companies due to extremely high development costs and numerous failures to successfully develop drugs. Joel Dudley and Laura Berliocchi's book

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
05 August 2016
Listed Since
15 April 2015

Barcode

No barcode data available

Similar Products You Might Like

Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)
99% match

Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)

CRC Press

£71.95 28 Feb 2026
Academic Press - Neurotherapeutics in the Era of Translational Medicine
94% match

Academic Press - Neurotherapeutics in the Era of Translational Medicine

Academic Press

£133.47 18 Apr 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
94% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£92.95 26 Feb 2026
Advances in Neuropharmacology: Drugs and Therapeutics
94% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£76.70 17 Mar 2026
Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)
94% match

Neurobiology of Huntington's Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

CRC Press

£125.00 31 Jan 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
94% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£52.49 21 Feb 2026
Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)
94% match

Neurobiology of Huntington’s Disease: Applications to Drug Discovery (Frontiers in Neuroscience)

CRC Press

£74.99 01 Mar 2026
Academic Press: Nanomedical Drug Delivery for Neurodegenerative Diseases
94% match

Academic Press: Nanomedical Drug Delivery for Neurodegenerative Diseases

Academic Press

£126.48 17 Apr 2026
Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders
94% match

Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders

Academic Press

£165.49 30 Jan 2026
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
94% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 23 Feb 2026
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)
94% match

Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Psychiatry - Theory, Applications and Treatments)

£139.49 07 Jan 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
93% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.02 09 Mar 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
93% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£207.59 10 Feb 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
93% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders
93% match

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Academic Press

£105.16 24 Feb 2026
Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)
93% match

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Humana

£150.58 30 Mar 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
93% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)
93% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (Enzyme Inhibitors)

CRC Press

£60.82 24 Feb 2026
Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies
93% match

Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies

Academic Press

£51.20 13 Feb 2026
Adenosine Receptors in Neurodegenerative Diseases
93% match

Adenosine Receptors in Neurodegenerative Diseases

Academic Press

£90.89 09 Feb 2026
Principles of Neurochemistry: Fundamentals and Applications
93% match

Principles of Neurochemistry: Fundamentals and Applications

Springer

£98.30 09 Mar 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
93% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£169.22 22 Jan 2026
Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)
93% match

Protein Misfolding in Neurodegenerative Diseases: Mechanisms and Therapeutic Strategies (CRC Enzyme Inhibitors)

CRC Press

£192.44 12 Jan 2026
Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)
93% match

Intracellular Traffic and Neurodegenerative Disorders (Research and Perspectives in Alzheimer's Disease)

Springer

£98.00 15 Jan 2026